Qiao Yu-huan, Li Liu-xia, Guo Rui-xia, Zhou Wei, Wang Miao, Zhang Xiao-yan, Zhang Jian-hao, Zhao Xian-lan, Zhang Meng-zhen, Zhao Guo-qiang
Department of Obstetrics and Gynecology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhonghua Fu Chan Ke Za Zhi. 2007 Nov;42(11):765-9.
To construct the recombinant eukaryotic expression vector pRNAT-U6.1-siEdg4 which carries small interfering RNA (siRNA) of Edg4 and observe the silencing effect of Edg4 gene targeted siRNA in ovarian cancer cell line SKOV3.
The Edg4 gene-targeted hairpin siRNA sequence was designed according to the Edg4 sequence in Genbank, and the two complementary oligo nucleotide strands were synthesized and annealed and inserted into the pRNAT-U6.1 plasmid to build a recombinant Edg4 siRNA eukaryotic expression vector, which was sequenced and identified to contain the correct Edg4 siRNA sequence. The human ovarian carcinoma cell lines SKOV3 were transfected with the vector using lipofectamine method. The efficiency of transfecting cells was observed with fluorescent microscope and the mRNA expression level of Edg4 gene was detected by real time quantitative PCR. The LPA levels in cell supernatants were detected using a biochemical method. And the apoptosis of SKOV3 cells induced by the vector was evaluated by flow cytometry.
The recombinant eukaryotic expression vector was confirmed to contain correct Edg4 siRNA sequence by PCR and sequencing. After transfection large amounts of green fluorescence were seen in plasma and nuclei of SKOV3 cells and the positive cell rates were 64%. The expression level of Edg4 mRNA in transfected SKOV3 cell line was significantly decreased (0.05 +/- 0.01vs 0.29 +/- 0.04, P < 0.05). The decrease in LPA level in the cell supernatants was revealed [(3.0 +/- 1.0) vs (7.5 +/- 2.2)micromol/L, P < 0.05]. The apoptosis rate of transfected SKOV3 was increased obviously (53.38% vs 0.51%, P < 0.05).
We have successfully constructed the recombinant eukaryotic expression vector containing Edg4 gene targeted siRNA (pRNAT-U6.1-siEdg4). The vector could effectively transfect SKOV3 cell line, and obviously suppress the Edg4 mRNA expression and induce cell apoptosis in ovarian cancer cell line SKOV3.
构建携带Edg4小干扰RNA(siRNA)的重组真核表达载体pRNAT-U6.1-siEdg4,并观察Edg4基因靶向siRNA对卵巢癌细胞系SKOV3的沉默效果。
根据Genbank中Edg4序列设计靶向Edg4基因的发夹状siRNA序列,合成两条互补寡核苷酸链并退火,插入pRNAT-U6.1质粒构建重组Edg4 siRNA真核表达载体,测序鉴定其含有正确的Edg4 siRNA序列。采用脂质体法将该载体转染人卵巢癌细胞系SKOV3。用荧光显微镜观察细胞转染效率,通过实时定量PCR检测Edg4基因的mRNA表达水平。采用生化方法检测细胞上清液中溶血磷脂酸(LPA)水平。通过流式细胞术评估该载体诱导SKOV3细胞凋亡的情况。
经PCR和测序证实重组真核表达载体含有正确的Edg4 siRNA序列。转染后SKOV3细胞的细胞质和细胞核中可见大量绿色荧光,阳性细胞率为64%。转染的SKOV3细胞系中Edg4 mRNA表达水平显著降低(0.05±0.01对0.29±0.04,P<0.05)。细胞上清液中LPA水平降低[(3.0±1.0)对(7.5±2.2)μmol/L,P<0.05]。转染的SKOV3细胞凋亡率明显升高(53.38%对0.51%,P<0.05)。
成功构建了含Edg4基因靶向siRNA的重组真核表达载体(pRNAT-U6.1-siEdg4)。该载体能有效转染SKOV3细胞系,明显抑制卵巢癌细胞系SKOV3中Edg4 mRNA表达并诱导细胞凋亡。